You can enrol in up to 20 courses during temporary access. You’ve reached this limit and can’t enrol in any more right now.
Once you have full access, you’ll be able to enrol without limit.
Bridging the gap between screening and diagnosis.
![]()
The Global Leadership Initiative on Malnutrition (GLIM) criteria is a consensus-based framework for diagnosing malnutrition in adults - developed by collective leadership of ASPEN, ESPEN, FELANPE and PENSA.1
Provides a minimum set of practical indicators for malnutrition diagnosis
Can be used across different healthcare settings
Designed to be used alongside validated screening and assessment tools
Diagnosing malnutrition is crucial to appropriate, timely treatment, while empowering patients to participate in their healthcare journey.2
![]()
GLIM provides a two-step approach to diagnosing malnutrition:3,4
![]()
RISK SCREENING
Using validated tools to identify risk of malnutrition
![]()
DIAGNOSTIC ASSESSMENT
Applying GLIM diagnostic indicators (phenotypic and aetiologic criterion) to determine malnutrition severity.
Malnutrition is confirmed if at least one phenotypic and one aetiologic criterion is met. Severity of malnutrition can then be determined based on phenotypic criteria.
RISK SCREENING
AT RISK FOR MALNUTRITION
+ Use validated screening tools
DIAGNOSTIC ASSESSMENT
ASSESSMENT CRITERIA
+ use validated screening tools
| + PHENOTYPIC • Non-volitional weight loss • Low body mass index • Reduced muscle mass | + AETIOLOGIC • Reduced food intake or assimilation • Disease burden / inflammatory condition |
DIAGNOSIS
MEETS CRITERIA FOR MALNUTRITION DIAGNOSIS
+ Requires at least 1 phenotypic criterion and 1 aetiologic criterion
SEVERITY GRADING
DETERMINE SEVERITY OF MALNUTRITION
+ Severity determined based on phenotypic criterion
Diagram adapted from Cederholm, 20193
![]()
Nutritional screening/assessment can be performed using any validated screening tool to identify patients who may be at risk of malnutrition.4
Malnutrition screening/assessment tools may include:4,5
The framework for diagnosing malnutrition in adult patients includes five key indicators that can be used during routine clinical practice. After comprehensive nutritional assessment has been conducted, clinicians can use these criterion to perform a more comprehensive diagnosis of malnutrition.4
The below tables outline the key GLIM diganostic criteria. During nutritional assessment, check if any of the below are present.
Phenotypic criteria4
Unintentional weight loss | Identify whethere there has been any unitentional weight loss using the below timeframes: • > 5% within past 6 months • > 10% beyond 6 months |
BMI (kg / m2) | Assess BMI according to age: • < 20 if patient is < 70 years • < 22 if patient is ≥ 70 years |
Muscle mass | Assess reduced muscle mass based on valid body composition assessment methods, such as: • Physical exam • Dual-energy absorptiometry • Bioelectrical impedance analysis • Ultrasound • Computer tomography • Magnetic resonance imagine • Mid upper arm circumference • Calf circumference |
Aetiologic criteria4,6
Reduce food intake or assimilation | Assess reduced food intake or assimilation using either quantitative or qualitative reports, for example 3-day food record, food frequency questionnaire or patient self-report. Considerations may include: • Ingestion ≤ 50% of needs from 1 to 2 weeks • Any reduction in food intake for >2 weeks • Whether the patient has any gastrointestinal symptoms that may impact food intake or absorption, such as:
|
Disease burden / Inflammation | Understand whether there may be presence of inflammation or disease burden from acute of chronic injury/disease:
|
Muscle screening tools are easy to use in clinical settings as they are quick and easy to implement and do not require specialist nutritional training or complex equipment.7
Various reliable screening methods exist to assess the risk of loss of muscle/muscle function.8
Find out more about how to screen/assess for loss of muscle/muscle function.
The occurrence of acute or chronic disease, infection or injury that is usually associated with inflammatory activity may fulfill the aetiologic GLIM inflammation criterion, which means confirmation by laboratory markers is not always necessary. This may include the presence of:6
For conditions with no clear or perceptible inflammation, such as psychiatric disorders (anorexia nervosa, depression), malabsorptive, dysmotility or obstructive disorders, neurological conditions, measuring laboratory markers using CRP levels can support inflammation assessment.6
Application for CRP testing are as follows:6
For acute conditions - CRP levels x 10 upper reference value:
For chronic conditions - Serial measures of CRP > upper reference value
![]()
Malnutrition diagnosis is confirmed when a patient meets at least 1 phenotypic and 1 aetiologic criterion.4
The table below outlines a simple way to determine malnutrition severity.4
Phenotypic Criteria | Unintentional weight loss (%) | Low BMI (kg / m2) | Reduced muscle mass |
|---|---|---|---|
Stage 1: Moderate Malnutrition Patient requires 1 phenotypic criteria that meets this grade |
|
| Mild-to-moderate deficit (per validated assessment methods outlined above) |
Stage 2: Severe Malnutrition Patient requires 1 phenotypic criteria that meets this grade |
|
| Severe deficit (per validated assessment methods outlined above) |
Adapted from ESPEN Framework for Diagnosing Adult Malnutrition,20234
![]()
Healthcare professionals are now able to code the diagnosis of malnutrition in the patient’s electronic health record.9,10
Diagnosis of malnutrition can be recorded at two levels on the patient record:10
• GLIM Stage 1: Moderate malnutrition
• GLIM Stage 2: Severe malnutrition
![]()
![]()
Once a diagnosis of malnutrition has been confirmed, healthcare professionals should consider strategies for optimising nutritional intake.11 Depending on the patient's nutritional risk,* there may be different strategies for managing nutrition:11
Dietary advice to optimise food intake
Oral nutritional supplements
May be used alongside dietary advice when food intake is insufficient
Agreeing on realistic goals
Involve the patient/carers to agree on a treatment plan and consider the impact of the disease and associated treatments
Examining guidelines and new evidence in oncology nutrition

Dr Steven Pearse-Danker details his clinical experience with nutritional support and highlights the critical value of nutrition in optimising patient care.
Sue is a 42 year old female patient with a subtotal colectomy and ileostomy.
![]()
Sue is a 42 year old female patient with a subtotal colectomy and ileostomy. She was admitted to hospital with chronic diarrhoea, and investigation showed evidence of ulceration of the ileosigmoid anastamosis and terminal ileum. During this admission she had numerous medical interventions such as steroid therapy, blood and ferritin transfusions, diuretics and a trial of Creon. She was fed via nasogastric (NG) feeding tube as she was only consuming half of her meals. Previously she had unsuccessfully trialled various whole protein oral nutritional supplements (ONS) and modular supplements, which she had felt exacerbated the diarrhoea.
Nutrition and exercise in maintaining muscle and strength in older adults

This article provides an overview of the management strategies and interventions that can help to maintain muscle mass.
Footnotes:
ASPEN - American Society for Parenteral and Enteral Nutrition. ESPEN - European Society for Clinical Nutrition and Metabolism. FELANPE - Federación Latinoamericana de Terapia Nutricional, Nutrición Clínica y Metabolismo. PENSA - Parenteral and Enteral Nutrition Society of Asia. BMI - Body Mass Index COPD - Chronic Obstructive Pulmonory Disease. ARDS – Acute respiratory distress syndrome. CRP – C-reactive protein
*Assuming patient can take nutrition orally
References:
1. de van der Schueren MAE et al. Clin Nutr 2019;39(9):2872-2880.
2. Jain D. Journal of Pharmaceutical Research and Clinical Practice 2023;6(3):74-77
3. Cederholm T et al. Clin Nutr 2019;38:1-9.
4. ESPEN 2023. A Global Leadership Initiative on Malnutrition (GLIM): A Framework for Diagnosing Adult Malnutrition. Available online: https://www.espen.org/files/GLIM-2-page-Infographic.pdf Last accessed February 2025.
5. Lima J et al. Clin Nutr 2022;41(10):2325-2332
6. ESPEN, 2024. Guidance for assessment of the inflammation etiologic criterion for the GLIM diagnosis of malnutrition. Available online: https://www.espen.org/images/files/ESPEN-Fact-Sheets/ESPEN-Fact-Sheet-GLIM-Inflammation.pdf Last accessed June 2025
7. Beaudart C. et al. Calcif Tissue Int 2019;105,1-14.
8. Cruz Jentoft A. et al. Age Ageing. 2019;48(1):16-31.
9. BDA, 2023. Capturing dietetic outcomes using the Model and Process. Available online: https://www.bda.uk.com/resource/capturing-dietetic-outcomes-using-the-model-and-process.html Last accessed Feburary 2025.
10. NHS Digital, 2025. SNOMED CT Browser. Available online: https://termbrowser.nhs.uk/?perspective=full&conceptId1=2492009&edition=uk-edition&release=v20241120&server=https://termbrowser.nhs.uk/sct-browser-api/snomed&langRefset=999001261000000100,999000691000001104 Last accessed February 2025
11. Malnutrition Pathway, 2021. Managing Adult Malnutrition in the Community. Available online: https://www.malnutritionpathway.co.uk/library/managing_malnutrition.pdf Last accessed May 2025
SESSION TIMEOUT
Please log in to continue
Thanks for registering. To begin, please log in to your ProConnect account. After you log in, you’ll have temporary access to all resources and education while we verify your details.
Added to Bag
ENSURE PLUS
1 x 220 ml
Flavor: Apple
1,5 kcal / ml
Nutrition Information
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
footnotes
Product details not available.
You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your account has not yet been approved. We’re validating your credentials. You won’t be able to order samples until your account is approved and activated. Please check your email for more details. For help, contact us at abbott.proconnect_access@nhs.net.
UK--2500192 | September 2025
You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your credentials are validated but not yet activated. To gain full access, including the ability to order samples, click the activation link we sent to your inbox. For help, contact us at abbott.proconnect_access@nhs.net.
UK--2500192 | September 2025
Register to continue reading this article
UK-N/A-2400058(v9) | September 2025
You are about to exit for another Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimised for your specific screen size.
Do you wish to continue and exit this website?
UK-N/A-2200465 | July 2022
This website is for UK HCPs and UK Patients only. If you are outside of the UK please visit our global website Abbott.com
If you choose "I am a patient/carer”, you will be entering a website intended for patients and carers which has information on Abbott products. Products on this website are to be used under medical supervision. If you have questions about the product information discussed on this website, you should consult with your healthcare professional.